Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program.
| Author | |
|---|---|
| Abstract |
:
This named patient program evaluated the safety and efficacy of ibrutinib, a selective inhibitor of Bruton's tyrosine kinase in Indian patients with relapsed/refractory chronic lymphocytic leukemia (CLL, with/without chromosome 17 deletion [del17p]) and mantle cell lymphoma (MCL). |
| Year of Publication |
:
1969
|
| Journal |
:
Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
|
| Volume |
:
38
|
| Issue |
:
4
|
| Number of Pages |
:
508-515
|
| Date Published |
:
1969
|
| ISSN Number |
:
0971-5851
|
| DOI |
:
10.4103/ijmpo.ijmpo_43_17
|
| Short Title |
:
Indian J Med Paediatr Oncol
|
| Download citation |
